Concepedia

Paul D. Crowe

PD

Statistics

Publications

52

Citations

3.9K

H-Index

31

Active since

1988

Affiliations

Neurocrine Biosciences (United States)(Current)

University of California, Riverside

University of South Florida

Orphagen Pharmaceuticals (United States)

Japan Tobacco (Japan)

Paul D. Crowe is an author at Neurocrine Biosciences (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1988–2019

52

Publications

52

The performance prism in practice

Andy Neely, Chris Adams, Paul D. Crowe · Measuring Business Excellence · 2001 · 641 citations

, , +19

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Paul D. Crowe, Barbara Walter, K M Mohler et al. · The Journal of Experimental Medicine · 1995 · 232 citations · Full text

, , +14

A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin

David G. Alleva, Paul D. Crowe, Liping Jin et al. · Journal of Clinical Investigation · 2001 · 210 citations · Full text

, , +17

Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells

Carl F. Ware, Paul D. Crowe, M H Grayson et al. · The Journal of Immunology · 1992 · 183 citations · Full text

Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells

Carl F. Ware, Paul D. Crowe, Todd VanArsdale et al. · The Journal of Immunology · 1991 · 177 citations

1–5 of 52